Literature DB >> 31838468

Long Non-Coding RNA-CASC15 Promotes Cell Proliferation, Migration, and Invasion by Activating Wnt/β-Catenin Signaling Pathway in Melanoma.

Liang Sheng1, Rong Wei2.   

Abstract

BACKGROUND: Melanoma is one of the most aggressive and high mortality skin cancers in the world. Long non-coding RNA-CASC15, as a carcinogen, plays an important role in a variety of tumorigenesis; however, the role and underlying mechanism of CASC15 in melanoma remain unclear.
METHODS: Quantitative real-time polymerase chain reaction was applied to explore CASC15 and β-catenin expression in melanoma tissues and cells. Western blotting was carried out to investigate β-catenin, glycogen synthase kinase-3β, Survivin, Bax, Bcl-2, and epithelial-mesenchymal transition (EMT)-related protein expression level. Cell proliferation, apoptosis, migration, and invasion were observed by colony formation assay, flow cytometry, and transwell migration and invasion assays, respectively. The activity of Wnt/β-catenin signaling pathway was measured by Topflash luciferase reporter assay.
RESULTS: The expression of CASC15 and β-catenin was upregulated in melanoma tissues and cells. Knockdown of CASC15 suppressed Wnt/β-catenin signaling pathway and inhibited β-catenin expression. Furthermore, inhibition of CASC15 decreased proliferation and increased apoptosis of melanoma cells by downregulating Survivin and Bcl-2 and upregulating Bax in A375 and SK-MEL-28 cells. Silencing of CASC15 inhibited migration and invasion of melanoma cells by repressing EMT process.
CONCLUSION: Our study demonstrated that CASC15 promoted the proliferation, migration, and invasion of melanoma cells via activating Wnt/β-catenin signaling pathway, implying that CASC15 might be a potential therapeutic target and prognostic biomarker for melanoma.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Cell proliferation; Epithelial–mesenchymal transition; Long noncoding RNA-CASC15; Melanoma; Wnt/β-catenin pathway

Year:  2019        PMID: 31838468     DOI: 10.1159/000502803

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  7 in total

1.  Long non‑coding RNA CASC15 facilitates esophageal squamous cell carcinoma tumorigenesis via decreasing SIM2 stability via FTO‑mediated demethylation.

Authors:  Bo Qin; Meng Dong; Zhengyang Wang; Jiajia Wan; Yingying Xie; Yi Jiao; Dan Yan
Journal:  Oncol Rep       Date:  2020-12-30       Impact factor: 3.906

2.  Downregulation of lncRNA FGF12-AS2 suppresses the tumorigenesis of NSCLC via sponging miR-188-3p.

Authors:  Lili Zhou; Chen Xing; Dongxia Zhou; Rong Yang; Maohuai Cai
Journal:  Open Med (Wars)       Date:  2020-10-08

3.  Hypoxia-sensitive long noncoding RNA CASC15 promotes lung tumorigenesis by regulating the SOX4/β-catenin axis.

Authors:  Jianyong Sun; Yanlu Xiong; Kuo Jiang; Bo Xin; Tongtong Jiang; Renji Wei; Yuankang Zou; Hong Tan; Tao Jiang; Angang Yang; Lintao Jia; Lei Wang
Journal:  J Exp Clin Cancer Res       Date:  2021-01-06

Review 4.  An Overview of Long Non-Coding (lnc)RNAs in Neuroblastoma.

Authors:  Francesca Baldini; Matilde Calderoni; Laura Vergani; Paola Modesto; Tullio Florio; Aldo Pagano
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

Review 5.  Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process.

Authors:  Marine Melixetian; Pier Giuseppe Pelicci; Luisa Lanfrancone
Journal:  Cells       Date:  2022-02-07       Impact factor: 6.600

6.  LncRNA CASC15, MiR-23b Cluster and SMAD3 form a Novel Positive Feedback Loop to promote Epithelial-Mesenchymal Transition and Metastasis in Ovarian Cancer.

Authors:  Hui Lin; Xian Xu; Kelie Chen; Zhiqin Fu; Shengchao Wang; Yaqing Chen; Honghe Zhang; Yuequn Niu; Hanwen Chen; Hongfei Yu; Jian-Zhong Shao; Weiguo Lu; Yihua Wu; Dajing Xia
Journal:  Int J Biol Sci       Date:  2022-02-21       Impact factor: 6.580

7.  Long non-coding RNA expression profiling of subchondral bone reveals AC005165.1 modifying FRZB expression during osteoarthritis.

Authors:  Margo Tuerlings; Marcella van Hoolwerff; Jessica M van Bokkum; H Eka D Suchiman; Nico Lakenberg; Demiën Broekhuis; Rob G H H Nelissen; Yolande F M Ramos; Hailiang Mei; Davy Cats; Rodrigo Coutinho de Almeida; Ingrid Meulenbelt
Journal:  Rheumatology (Oxford)       Date:  2022-07-06       Impact factor: 7.046

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.